BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 8, 2026
Home » Authors » David Ho

Articles by David Ho

NUS, NUH and Agilent set up SG$38M facility for clinical diagnostics in Singapore

Sep. 9, 2019
By David Ho

Putting the AI in ASEAN

Sep. 4, 2019
By David Ho
HONG KONG – At the recent Beyond Paradigm Summit 2019 in Kuala Lumpur, a Malaysian company unveiled the country's first humanoid robot.
Read More

Putting the AI in ASEAN

Aug. 29, 2019
By David Ho

Putting the AI in ASEAN

Aug. 29, 2019
By David Ho
HONG KONG – At the recent Beyond Paradigm Summit 2019 in Kuala Lumpur, a Malaysian company unveiled the country's first humanoid robot. ADAM, an acronym for Advanced Development Autonomous Machine, is built for natural speech and the detection of emotions. While still early in its development, ADAM represents a leap that Malaysia, and perhaps Southeast Asia, is making in the realm of artificial intelligence (AI).
Read More

Indian government sets up MDTAG to advise regulators on med tech

Aug. 20, 2019
By David Ho

Singapore's two-year pilot to support biotech, med-tech firms

Aug. 7, 2019
By David Ho and Elise Mak
HONG KONG – The Singapore government will be launching a pilot program that could help biotech and med-tech companies thrive in both the country and Asia. The two-year pilot, Tech@SG, set up by the Economic Development Board (EDB) and Enterprise Singapore, aims to provide companies access to business networks and talent.
Read More

Singapore to launch pilot to support biotechnology and med-tech firms

Aug. 6, 2019
By David Ho and Elise Mak

Singapore's two-year pilot to support biotech, med-tech firms

Aug. 5, 2019
By David Ho and Elise Mak
HONG KONG – The Singapore government will be launching a pilot program that could help biotech and med-tech companies thrive in both the country and Asia. The two-year pilot, Tech@SG, set up by the Economic Development Board (EDB) and Enterprise Singapore, aims to provide companies access to business networks and talent.
Read More

Israel's Dia Imaging partners with Konica for AI analysis solution

July 11, 2019
By David Ho
HONG KONG – Dia Imaging Analysis Ltd., of Be'er Sheva, Israel, has teamed up with Konica Minolta Healthcare Americas Inc. to explore the analytic potential of Dia's Lvivo Toolbox for cardiac analysis combined with Konica Minolta's Exa cardio PACS platform.
Read More

Incyte licenses China rights to PD-1 candidate in Zai deal

July 10, 2019
By David Ho
HONG KONG – Incyte Corp. entered a collaboration and licensing deal to flip its greater China rights to an investigational anti-PD-1 monoclonal antibody to Zai Lab Ltd., of Shanghai. The candidate, INCMGA-0012, is currently being evaluated as a monotherapy in registration-directed trials for patients with MSI-high endometrial cancer, Merkel cell carcinoma and anal cancer.
Read More
Previous 1 2 … 36 37 38 39 40 41 42 43 44 … 71 72 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 8, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • CAR T cell attacking cancer cells

    Development and characterization of anti-CD19 in vivo CAR T therapy

    BioWorld Science
    Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
  • Icons representing scientific research

    Science in 2025: the best of the rest

    BioWorld Science
    A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing